These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 30298667

  • 1. Advanced therapeutics in focal and segmental glomerulosclerosis.
    Liu Y, Shi Y, Ren R, Xie J, Wang W, Chen N.
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():57-61. PubMed ID: 30298667
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive treatment in primary focal segmental glomerulosclerosis.
    Xu S, Xu G, Zeng L.
    J Nephrol; 2012 Oct; 25(5):626-35. PubMed ID: 22344540
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R, Nada R, Yadav AK, Kumar A, Goyal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.
    Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
    [Abstract] [Full Text] [Related]

  • 4. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
    Jayaraman VK, Thomas M.
    BMJ Case Rep; 2016 Feb 17; 2016():. PubMed ID: 26887886
    [Abstract] [Full Text] [Related]

  • 5. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
    Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A.
    Am J Kidney Dis; 1999 Oct 17; 34(4):618-25. PubMed ID: 10516340
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
    Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.
    Transplantation; 2017 Mar 17; 101(3):649-656. PubMed ID: 27043407
    [Abstract] [Full Text] [Related]

  • 7. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
    Wee Leng G, Mustafar R, Kamaruzaman L, Mohd R, Cader RA, Wei Yen K, Kiew Bing P.
    Acta Med Indones; 2018 Jul 17; 50(3):237-243. PubMed ID: 30333274
    [Abstract] [Full Text] [Related]

  • 8. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
    Hari P, Bagga A, Jindal N, Srivastava RN.
    Pediatr Nephrol; 2001 Nov 17; 16(11):901-5. PubMed ID: 11685598
    [Abstract] [Full Text] [Related]

  • 9. Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors.
    Segarra-Medrano A, Jatem-Escalante E, Agraz-Pamplona I, Carnicer-Cáceres C, Ramos-Terrades N, Ostos-Roldán E, Quiles-Pérez MT, Arbós-Via MA.
    Nefrologia; 2013 Nov 17; 33(4):448-61. PubMed ID: 23897176
    [Abstract] [Full Text] [Related]

  • 10. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
    Expert Opin Investig Drugs; 2018 Nov 17; 27(11):839-879. PubMed ID: 30360670
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 17; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 17; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation.
    Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR.
    Pediatr Nephrol; 2024 Nov 17; 39(11):3317-3331. PubMed ID: 39001911
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec 17; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 15. Treatment of FSGS in Children.
    Sethna CB, Gipson DS.
    Adv Chronic Kidney Dis; 2014 Mar 17; 21(2):194-9. PubMed ID: 24602468
    [Abstract] [Full Text] [Related]

  • 16. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
    Tatangelo P, Londrino F, Di Vasta G, Guido G, Centi A, Dominijanni S, Bernabei E, Caramiello MS, Di Franco D, Palumbo R.
    G Ital Nefrol; 2018 May 17; 35(3):. PubMed ID: 29786187
    [Abstract] [Full Text] [Related]

  • 17. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH, Kim SH.
    Biomed Res Int; 2016 May 17; 2016():3053706. PubMed ID: 27195285
    [Abstract] [Full Text] [Related]

  • 18. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
    Shiiki H, Nishino T, Uyama H, Kimura T, Nishimoto K, Iwano M, Kanauchi M, Fujii Y, Dohi K.
    Clin Nephrol; 1996 Dec 17; 46(6):362-8. PubMed ID: 8982551
    [Abstract] [Full Text] [Related]

  • 19. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome].
    Niang A, Hachim K, Zahiri K, Fatihi E, Benghanem M, Ramdani B, Sqalli S, Zaid D.
    Dakar Med; 2004 Dec 17; 49(1):13-6. PubMed ID: 15782470
    [Abstract] [Full Text] [Related]

  • 20. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
    Colucci M, Labbadia R, Vivarelli M, Camassei FD, Emma F, Dello Strologo L.
    Pediatr Nephrol; 2020 Feb 17; 35(2):341-345. PubMed ID: 31667616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.